Adams, R. M., & Gonik, B. (2024). The Evolving Maternal Vaccine Platform. Reproductive Medicine, 5(3), 154–171. https://doi.org/10.3390/reprodmed5030014
Alghounaim, M., Alsaffar, Z., Alfraij, A., Bin-Hasan, S., & Hussain, E. (2022). Whole-cell and acellular pertussis vaccine: reflections on efficacy. Medical Principles and Practice, 31(4), 313-321. https://doi.org/10.1159/000525468
Banda, G., Mugwagwa, J., Mackintosh, M., & Mkwashi, A. (2022). The Localisation of Medical Manufacturing in Africa. URL: https://www.iej.org.za/localisation-of-medical-man...
Jansen, M. C. (2022). The relationship between the nutritional status of children within early childhood development centres in delft and their compliance to the expanded programme of immunization and routine vitamin a supplementation. [Dissertation] ttps://hdl.handle.net/10566/11195
Kana, B. D., Arbuthnot, P., Botwe, B. K., Choonara, Y. E., Hassan, F., Louzir, H., Matsoso, P., Moore, P. L., Muhairwe, A., & Naidoo, K. (2023). Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa. The Lancet Infectious Diseases, 23(8), e288–e300. https://www.thelancet.com/action/showPdf?pii=S1473-3099%2822%2900878-7
Kour, I., Singhal, L., & Gupta, V. (2023). Diphtheria: A paradigmatic vaccine-preventable toxigenic disease with changing epidemiology. In Recent Advances in Pharmaceutical Innovation and Research (pp. 749–759). Springer.
Madhi, S. A., Mitha, I., Cutland, C., Groome, M., & Santos-Lima, E. (2011). Immunogenicity and safety of an investigational fully liquid hexavalent combination vaccine versus licensed combination vaccines at 6, 10, and 14 weeks of age in healthy South African infants. The Pediatric Infectious Disease Journal, 30(4), e68-e74. Open here
Nnaji, C. (2024). Assessing and addressing missed opportunities for vaccination in Cape Town through a collaborative quality improvement approach. [Dissertation] http://hdl.handle.net/11427/40377
Nnaji, C. A., Wiysonge, C. S., Adamu, A. A., Lesosky, M., Mahomed, H., & Ndwandwe, D. (2022). Missed opportunities for vaccination and associated factors among children attending primary health care facilities in Cape Town, South Africa: A pre-intervention multilevel analysis. Vaccines, 10(5), 785. https://doi.org/10.3390/vaccines10050785
Pilusa, T. D. (2021). Prevalence and determinants of childhood vaccination coverage at selected primary health care facilities, Bushbuckridge Sub-District, Mpumalanga Province, South Africa. [Dissertation] http://hdl.handle.net/10386/3616
Sadarangani, M., Kollmann, T., Bjornson, G., Heath, P., Clarke, E., Marchant, A., Levy, O., Leuridan, E., Ulloa-Gutierrez, R., & Cutland, C. L. (2021). The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing protection for the next generation. Msphere, 6(1), 10.1128/msphere. 00862-20. https://doi.org/10.1128/msphere.00862-20
Saso, A., Roetynck, S., Okoye, M., Kanteh, E., Kumado, M., Roberts, E., Faal, A., Jobe, H., Jeffries, D., & Kelly, D. (2024). The impact of acellular pertussis vaccination in pregnancy on the immunogenicity of acellular versus whole-cell pertussis vaccines in infancy: A protocol for a phase IV randomised, controlled mother-infant pertussis vaccine trial (The Gambian Pertussis Study, GaPs). Wellcome Open Research, 9, 487. [Protocol] https://wellcomeopenresearch.org/articles/9-487
Szwejser-Zawislak, E., Wilk, M. M., Piszczek, P., Krawczyk, J., Wilczyńska, D., & Hozbor, D. (2022). Evaluation of whole-cell and acellular pertussis vaccines in the context of long-term herd immunity. Vaccines, 11(1), 1. https://doi.org/10.3390/vaccines11010001
von Hunolstein, C., Schofield, T., Sloots, A., Gairola, S., Riyanti, I., Resnawati, E., ... & Sharma, S. (2024). POTENCY TESTING OF WHOLE-CELL PERTUSSIS-CONTAINING VACCINES: RESULTS OF MULTILABORATORY ASSESSMENT OF THE PERTUSSIS SEROLOGICAL POTENCY TEST. WHO Drug Information, 38(4). (NOT OA)